Use of Ultrarapid Acting Insulin

• 收藏
• 分享

专利权人:

MannKind Corporation

发明人:

Anders Hasager Boss,Richard Petrucci

申请号：

US16385915

公开号：

US20190307853A1

申请日:

2019.04.16

申请国别(地区):

US

年份:

2019

代理人:

摘要：

Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/